The Supreme Court’s June 25, 2026, decision in Monsanto Company v. Durnell marks the most significant interpretation of FIFRA’s preemption provision since the earlier Bates v. Dow Agrosciences ruling. The landmark ruling
More
As the US Environmental Protection Agency’s federal Greenhouse Gas Reporting Programme remains unresolved, states across the country are moving to strengthen their own reporting frameworks. The EPA published a proposed rule in
More
The Supreme Court’s October Term 2025 delivered consequential rulings for environmental law, even though environmental cases were not the central focus of the merits docket. The Court’s decisions addressed foundational issues including
More
On June 25, 2026, the U.S. Supreme Court ruled in Monsanto Co. v. Durnell, No. 24-1068, that federal pesticide law preempts state tort claims over missing cancer warnings on Roundup labels. The
More
London equities managed modest gains on Monday as rising oil prices lifted energy stocks, helping the market absorb fresh geopolitical shock from renewed U.S. military action against Iran. The FTSE 100 rose
More
Genco Shipping & Trading (GNK) has filed a $40.7 million shelf registration, a move that arrives as its bid for Diana Shipping remains open. Shelf registrations allow publicly traded companies to register
More
Greggs (GRG) has been a frustrating holding for many retail investors, with shares underperforming expectations over a prolonged period. The British bakery chain, once celebrated as one of the UK stock market’s
More
England fans chasing a place in World Cup history will need deep pockets, with tickets for Wednesday’s semi-final against Argentina starting at $2,700. The Three Lions secured their spot in the last
More
BioMarin has launched a three-episode video podcast series called “Why Do I Pheel This Way?” aimed at teens living with phenylketonuria, known as PKU. The campaign centres on real conversations about the
More
As access to GLP-1 medications widens across the United States, pharmacies are emerging as one of the most important pillars of long-term treatment success. Medicare’s expansion of GLP-1 access, including pathways toward
More